Addex Therapeutics Ltd.: Form 20-F for the period ended Dec 31, 2022
Filed with the SEC on Mar 30, 2023 and accepted by EDGAR at Mar 30, 2023, 06:04 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2022-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2022-01-01 to 2022-12-31 | CHF 1.4m | ifrs-full:RevenueFromContractsWithCustomers |
| Operating income | 12 months2022-01-01 to 2022-12-31 | −CHF 20.5m | ifrs-full:ProfitLossFromOperatingActivities |
| Income tax | 12 months2022-01-01 to 2022-12-31 | CHF 0 | ifrs-full:IncomeTaxExpenseContinuingOperations |
| Net income | 12 months2022-01-01 to 2022-12-31 | −CHF 20.8m | ifrs-full:ProfitLoss |
| Diluted EPS | 12 months2022-01-01 to 2022-12-31 | −CHF 0.46 | ifrs-full:DilutedEarningsLossPerShare |
| Basic EPS | 12 months2022-01-01 to 2022-12-31 | −CHF 0.46 | ifrs-full:BasicEarningsLossPerShare |
| Operating cash flow | 12 months2022-01-01 to 2022-12-31 | −CHF 16.4m | ifrs-full:CashFlowsFromUsedInOperatingActivities |
| Capital expenditure | 12 months2022-01-01 to 2022-12-31 | CHF 581 | ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities |
| Cash and equivalents | At period end2022-12-31 | CHF 7.0m | ifrs-full:CashAndCashEquivalents |
| Current assets | At period end2022-12-31 | CHF 7.8m | ifrs-full:CurrentAssets |
| Total assets | At period end2022-12-31 | CHF 8.3m | ifrs-full:Assets |
| Current liabilities | At period end2022-12-31 | CHF 3.3m | ifrs-full:CurrentLiabilities |
| Shareholders' equity | At period end2022-12-31 | CHF 4.9m | ifrs-full:Equity |
| Shares outstanding | At period end2022-12-31 | 77,134,020 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0001104659-23-038581. Last ingested by Listed: Oct 29, 2026, 06:06 ET. Listed shows no prices and gives no investment advice.